Related Experiment Video

Updated: Jul 8, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

New insights into the function of IAP proteins: modulation of the MYC/MAX/MAD network

Casey W Wright1, Colin S Duckett

  • 1Department of Pathology, The University of Michigan Medical School, Ann Arbor, MI 48109, USA.

Developmental Cell
|January 16, 2008
PubMed

Insights

Inhibitor of apoptosis proteins (IAPs) have diverse cellular functions. A new study shows c-IAP1 enhances Myc activity by degrading its inhibitor, Mad1, via ubiquitination and proteasomal pathways.

Area of Science:

  • Cellular biology
  • Molecular biology
  • Biochemistry

Background:

  • Inhibitor of apoptosis (IAP) proteins regulate diverse cellular processes beyond apoptosis suppression.
  • The precise mechanisms by which IAPs influence other cellular pathways are under active investigation.

Purpose of the Study:

  • To elucidate the role of c-IAP1, a member of the IAP family, in regulating the activity of the oncogenic transcription factor Myc.
  • To investigate the molecular mechanism by which c-IAP1 modulates Myc activity.

Main Methods:

  • The study employed molecular biology techniques to analyze protein interactions and degradation pathways.
  • Investigated the ubiquitination and proteasomal degradation of Mad1 in the presence and absence of c-IAP1.

Main Results:

  • Demonstrated that c-IAP1 directly interacts with the Myc inhibitory protein Mad1.
  • Showed that c-IAP1 promotes the ubiquitination and subsequent proteasomal degradation of Mad1.
  • Concluded that c-IAP1 potentiates Myc activity by removing its negative regulator, Mad1.

Conclusions:

  • c-IAP1 plays a crucial role in potentiating Myc activity through the degradation of Mad1.
  • This finding reveals a novel regulatory mechanism linking IAPs to the control of Myc, a key oncogene.

More Related Videos

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration10:43

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration

Published on: May 19, 2016

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...